Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 95   

Articles published

ARNA 2.15 +0.02 (0.94%)
price chart
What Next for Arena Pharmaceuticals, Inc. After Forming Bullish Descending ...
The stock of Arena Pharmaceuticals, Inc. (ARNA) formed a descending triangle with $3.12 target or 45.00% above today's $2.15 share price.
Arena Pharmaceuticals Incorporated (NASDAQ:ARNA) Ratings Update  The Bulletin
Arena Pharmaceuticals, Inc. Short Interest Update
The short interest in Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has declined from 25,879,900 on October 30,2015 to 24,340,204 on November 13,2015.
Could Arena Pharmaceuticals, Inc. Change Direction After Today's Huge ...
Price Target Update on Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares are expected to touch $3.75 in the short term. This short term price target has been shared by 4 analysts.
Arena Pharmaceuticals to Host Analyst & Investor Day on December 3rd  PR Newswire (press release)
Arena Pharmaceuticals Given Consensus Recommendation of "Buy" by ...  Dakota Financial News
Arena Pharmaceuticals, Inc. Analyst Rating Update
Research firm Zacks has rated Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and has ranked it at 3, indicating that for the short term the shares are a hold.
Arena Pharmaceuticals Inc.: Arena Pharmaceuticals to Host Third Quarter 2015 ...  The Wall Street Transcript
Arena Pharmaceuticals Upgraded by Zacks to "Buy" (ARNA)  Dakota Financial News
Earnings Reaction History: Arena Pharmaceuticals, Inc., 42.9% Follow-Through ...
Over the prior three fiscal years (12 quarters), when shares of ARNA rose in the extended-hours session in reaction to its earnings announcement, history shows that 25.0% of the time (1 event) the stock posted additional gains in the following regular ...
Company Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Rally 16.85%
Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) appreciated by 16.85% during the past week but lost 11.11% on a 4-week basis.
Arena Pharmaceuticals Shares Up 2.5% (ARNA)  Putnam Standard
Analysts Set Arena Pharmaceuticals PT at $4.90 (NASDAQ:ARNA)  Intercooler
Arena Pharmaceuticals to Present at Piper Jaffray 27th Annual Healthcare ...
24, 2015 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the company is scheduled to present a corporate overview and update at the Piper Jaffray 27th Annual Healthcare Conference on Wednesday, December 2, 2015 ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Short Interest Update
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) saw a drop of 11% or -3,212,866 shares in the short positions. The number dropped from 29,092,766 on October 15,2015 to 25,879,900 on October 30,2015.
Arena Pharm (ARNA) is Reiterated by RBC Capital Mkts to Sector Perform ...  Money Flow Index
Arena Pharmaceuticals Inc (NASDAQ:ARNA) Quarterly Sentiment Report
Arena Pharmaceuticals Inc (NASDAQ:ARNA) hedge funds sentiment decreased to 0.98 in Q2 2015. Its down -0.26, from 1.24 in 2015Q1.
Company Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Drops by -19.23%
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has lost 19.23% during the past week and dropped 4.55% in the last 4 weeks.
Brokerages Set Arena Pharmaceuticals Price Target at $5.60 (NASDAQ:ARNA)  Voice Chronicle
Arena Pharmaceuticals (ARNA) Set to Announce Earnings on Monday  Dakota Financial News